Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial

Mahaffey, Kenneth W., Wojdyla, Daniel M., Carroll, Kevin, Becker, Richard C., Storey, Robert F., Angiolillo, Dominick J., Held, Claes, Cannon, Christopher P., James, Stefan, Pieper, Karen S., Horrow, Jay, Harrington, Robert A., Wallentin, Lars·2011·Circulation
DOI 10.1161/circulationaha.111.047498

Cited by (434)

Items 301–400 of 434

  1. What's New in Antiplatelet and Anticoagulant Therapy Recommendations for Unstable Angina/Non–ST‐Elevation Myocardial Infarction
    NANETTE KASS WENGER · 2012 · Clinical Cardiology
  2. Ticagrelor for acute coronary syndromes
    Sameer Bansilal, Marc P. Bonaca, Marc Steven Sabatine · 2013 · Expert Review of Cardiovascular Therapy
  3. Aspirin Hypersensitivity in Patients Undergoing Percutaneous Coronary Intervention. What Should We be Doing?
    George Kassimis, Tushar Raina, Dimitrios K. Alexopoulos · 2018 · Current Vascular Pharmacology
  4. Laboratory Monitoring of Antiplatelet Therapy
    Thomas Gremmel, Deepak L. Bhatt, Alan D. Michelson · 2019 · Elsevier eBooks
  5. Aspirin
    Carlo Patrono · 2017 · Springer eBooks
  6. Acute Coronary Syndrome
    Brandon William Calenda, Umesh K Gidwani · 2016 · IGI Global eBooks
  7. Antiplatelet Agents in Acute Coronary Syndromes
    Pedro Beraldo de Andrade, Leonardo Roever · 2017 · International Journal of Cardiovascular Sciences
  8. Ticagrelor versus clopidogrel in patients with ST-elevation myocardial infarction: postdischarge mild bleeding and its clinical impacts
    Li Song, Chen Liu, Peng Zhou, Jinying Zhou, Zhaoxue Sheng, Jiannan Li, Runzhen Chen, Yi Chen, Hanjun Zhao, Hongbing Yan · 2020 · Coronary Artery Disease
  9. 'Reversible nature of platelet binding causing transfusion-related acute lung injury (TRALI) syndrome may explain dyspnea after ticagrelor and elinogrel' – a hypothesis that remains unproven
    Karsten Schrör · 2012 · Thrombosis and Haemostasis
  10. Cyclooxygenase inhibition and rosuvastatin-induced vascular protection in the setting of ischemia–reperfusion: A human in vivo study
    Wilson Kwong, Andrew Liuni, Kangbin Zhou, John D. Parker · 2015 · Vascular Pharmacology
  11. An emerging consensus
    Deborah Leipziger · 2017 · Routledge eBooks
  12. Comparison of Ticagrelor with Clopidogrel in Reducing Interleukin-17 and Myeloperoxidase Expression in Thrombus and Improving Postprocedural Coronary Flow in ST-segment Elevation Myocardial Infarction Patients
    WenHua Li, Songqi Guo, Wang Shu, Xin Sun, Zhu-Qin Li, Xinyong Sun, Yanming Sun, LanFeng Wang, Wei Pan · 2018 · Journal of Pharmacy & Pharmaceutical Sciences
  13. Aspirin
    Carlo Patrono · 2012 · Elsevier eBooks
  14. A Comprehensive Acute Coronary Syndrome Algorithm for Centers With Percutaneous Coronary Intervention Capability
    Michael McDaniel, Michael A. Ross, Syed Tanveer Rab, Matthew T. Keadey, Henry A. Liberman, Corinne R. Fantz, Anne M Winkler, Abhinav Goyal, Aloke Virmani Finn, Anwar Dayan Osborne et al. · 2013 · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine
  15. Pharmacological Therapy in the Management of Acute Coronary Syndromes
    Andrew J. Sampson, Timir Kumar Paul, George A. Stouffer · 2015 · Atherosclerosis
  16. A Delicate Balance
    Dhruv S. Kazi, Mark Andrew Hlatky · 2015 · Journal of the American College of Cardiology
  17. Novel antithrombotic agents 2 Clinical evidence for oral antiplatelet therapy in acute coronary syndromes
    Stephen D. Wiviott, Philippe Gabríel Steg · 2015
  18. Peri-Myocardial Infarction Pericarditis: Current Concepts
    Gharacholou S Michael, Vaca-Cartagena F Bryan, Pragnesh P. Parikh, Peter M. Pollak, Bruce Charles · 2019 · Clinical Cardiology and Cardiovascular Medicine
  19. Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors
    Saket R. Girotra, Amanda Stebbins, Lisa Miller Wruck, Guillaume Marquis‐Gravel, Kamal Gupta, Peter M. Farrehi, Catherine Pastorius Benziger, Mark B. Effron, Jeff Whittle, Daniel Muñoz et al. · 2023 · Journal of the American Heart Association
  20. Ticagrelor — a legend of modern cardiology
    S. R. Gilyarevskiy · 2024 · Russian Journal of Cardiology
  21. Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes trial (TC4): a Bayesian pragmatic cluster randomized controlled trial
    Stan Kutcher, Nandini Dendukuri, Sonny Dandona, Lyne Nadeau, James M. Brophy · 2025 · Canadian Medical Association Journal
  22. Optimum Utilisation of Novel Antiplatelet Agents in Clinical Practice
    Timm Bauer, Christian W. Hamm · 2014 · Interventional Cardiology Reviews Research Resources
  23. Adjunctive Pharmacologic Therapies in Acute Myocardial Infarction
    Richard G. Bach · 2019 · Elsevier eBooks
  24. Antiplatelet and antithrombotic therapy in diabetic patients recent updates
    Mohammed Ashfaq, Jaffer Syed, Abdul Mushtaq Mohammed, Shaista Sumayya, S P Srinivas Nayak · 2021 · International journal of applied research
  25. Antiplatelet strategies in acute coronary syndromes: design and methodology of an international collaborative network meta-analysis of randomized controlled trials
    Mahesh V. Madhavan, Behnood Bikdeli, Björn Redfors, Giuseppe Biondi‐Zoccai, Nicholas Varunok, John Burton, Aaron Crowley, Dominic P. Francese, Aakriti Gupta, Caroline A Der-Nigoghossian et al. · 2021 · Minerva Cardiology and Angiology
  26. Neue Arzneimittel 2011
    U. Schwabe, Uwe Fricke · 2012 · Springer eBooks
  27. Biometrische Entscheidungsunterstützung in Zulassung und Nutzenbewertung am Beispiel der Implikationen von heterogenen Ergebnissen in Untergruppen der Studienpopulation
    Andrea Gonnermann, Martina Kottas, Armin Koch · 2015 · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
  28. Pharmacokinetics and pharmacodynamics of ticagrelor when treating non-ST elevation acute coronary syndromes
    Francesco Monitillo, Massimo Iacoviello, Pasquale Caldarola, Roberto Valle, Mario Chiatto, Nadia Aspromonte · 2015 · Expert Opinion on Drug Metabolism & Toxicology
  29. Protecting the pipeline of science: Openness, scientific methods and the lessons from ticagrelor and the PLATO trial
    Andrew J.S. Coats, Sukhjinder Singh Nijjer, Dárrel P. Francis · 2014 · International Journal of Cardiology
  30. P2Y12 Antagonists: Pharmacology, Efficacy and Patient Considerations
    Raji Shameem, Muhammad Saad Hamid, Arvind Randhawa, Colette Spaccavento, Kirk Garatt · 2014
  31. Contemporary Reviews in Cardiovascular Medicine Antithrombotic Therapy in Patients With Chronic Kidney Disease
    Davide Capodanno, Dominick Joseph Angiolillo · 2012
  32. Acute Coronary Syndrome
    Brandon William Calenda, Umesh K Gidwani · 2015 · Advances in medical technologies and clinical practice book series
  33. Unstable Angina/Non-ST Elevation Myocardial Infarction
    Jason Evanchan · 2020 · Springer eBooks
  34. Antiplatelet and Anticoagulant Drugs
    Grégory Ducrocq, Philippe Gabríel Steg · 2017 · Elsevier eBooks
  35. Acute Myocardial Infarction
    Kalpa De Silva, Divaka Perera, Peter D. O’Kane · 2018 · Elsevier eBooks
  36. What Is the Question?
    Lawrence M. Friedman, Curt Daniel Furberg, David L. DeMets, David M. Reboussin, Christopher Bull Granger · 2015 · Springer eBooks
  37. PHILO – Ensuring Trial Results Are Not Lost in Translation –
    Amy A. Sarma, Michelle L. O’Donoghue · 2015 · Circulation Journal
  38. New research strategy with ambiguous implications: A comment on “Planning future studies based on the conditional power of a meta‐analysis”
    Kristina Weber, Florian Lasch, Armin Koch · 2018 · Statistics in Medicine
  39. [Doping: health risks and relation to addictive behaviors].
    Françoise Siri, Bernard Pierre Roques · 2003 · PubMed
  40. The efficacy and safety of the prasugrel, ticagrelor, and clopidogrel dual antiplatelet therapies following an acute coronary syndrome: A systematic review and Bayesian network meta-analysis
    Stan Kutcher, Leah K. Flatman, Rachelle Haber, Nandini Dendukuri, Sonny Dandona, James M. Brophy · 2023 · medRxiv
  41. P2Y12 inhibitors for acute coronary syndromes: current perspectives
    James J. Nawarskas, Cheyenne C. Newsome, Joe R. Anderson, Bina Ahmed · 2015 · Research Reports in Clinical Cardiology
  42. Antiplatelet Therapy in Acute Coronary Syndromes: Ticagrelor
    Steen Husted · 2012 · Advances in cardiology
  43. Perioperative Antiplatelet Management in Patients with Coronary Artery Stenting
    Anwar Tandar, Krishna Velagapudi, Brent D. Wilson, William E. Boden · 2012 · Hospital Practice
  44. Ticagrelor for the treatment of peripheral arterial disease
    Aun‐Yeong Chong, Derek Y F So · 2014 · Expert Opinion on Investigational Drugs
  45. Frequency of the Use of Low- Versus High-Dose Aspirin in Dual Antiplatelet Therapy After Percutaneous Coronary Intervention (from the Dual Antiplatelet Therapy Study)
    Alexis Matteau, Robert W. Yeh, Dean Kereiakes, Endel John Orav, Joseph M. Massaro, Philippe Gabríel Steg, Sharon‐Lise T. Normand, Donald E. Cutlip, Laura Mauri · 2013 · The American Journal of Cardiology
  46. Pharmacotherapy for the reduction of stent thrombosis
    David Chang-Sing Yang, Rajesh V. Swaminathan, Luke K. Kim, Dmitriy N. Feldman · 2013 · Expert Review of Cardiovascular Therapy
  47. Lessons from platelet inhibition and patient outcomes
    Claes Held · 2012 · Current Opinion in Cardiology
  48. Evidenced-Based Antithrombotic Therapy for Acute Coronary Syndromes
    Stefan Karl James · 2013 · Diabetes
  49. New Drugs and Devices from 2011-2012 That Might Change Your Practice
    Joe Lex · 2013 · Western Journal of Emergency Medicine
  50. Efficacy and Safety of Insulin Glargine 300 U/mL in North Americans and Non-North Americans with Type 2 Diabetes: A Patient-Level Meta- Analysis of the EDITION 1, 2 and 3 Studies
    IRENE M. HRAMIAK, Zubin Punthakee, Mélanie Groleau, Pasha Javadi, Grégory Bigot, Vincent C. Woo · 2017 · Journal of Diabetes & Metabolism
  51. Non-ST-Elevation Acute Coronary Syndromes
    Samad Ghaffari · 2021 · Elsevier eBooks
  52. Circulation Editors' Picks
    The Editors · 2012 · Circulation
  53. Short-term Clinical Outcomes of Ticagrelor versus Clopidogrel after Percutaneous Coronary Intervention in Patients with Myocardial Infarction: A Randomized Clinical Trial Study
    Salman Nikfarjam, Yasaman Borghei, Arsalan Salari, Seyyed Mehrad Miraftabi, Bahare Gholami Chaboki, Seyyed Aboozar Fakhr-Moosavi · 2023 · Research in Cardiovascular Medicine
  54. Regional differences in outcomes with ablation versus drug therapy for atrial fibrillation: Results from the CABANA trial
    Riccardo Cappato, Daniel B. Mark, Adam P. Silverstein, Peter A. Noseworthy, Gianluca Bonitta, Jeanne E. Poole, Jonathan Paul Piccini, Tristram D. Bahnson, Melanie R. Daniels, Hussein R. Al‐Khalidi et al. · 2024 · American Heart Journal
  55. Comparison of ticagrelor and clopidogrel in anemic patients with acute coronary syndrome: efficacy and safety outcomes over one year
    Tolga Onuk, Fuat Polat, Barış Yaylak, Şükrü Akyüz, Zeynep Kolak, Furkan Durak · 2024 · European Journal of Clinical Pharmacology
  56. Comparative Analysis of Ticagrelor and Clopidogrel Effects on Medication Adherence, Adverse Events, and Laboratory Parameters in Iranian Acute Coronary Syndrome Patients Post-PCI
    Vida Hamrahi, Mehdi Pishgahi, Alireza Javan, Roya Hamrahi, Mohamad Esmail Ghaidari · 2024 · International Journal of Cardiovascular Practice
  57. Antiplatelet Agents: Current and Novel
    Stan Heptinstall · 2012 · Springer eBooks
  58. An update on management of the patient presenting with non-ST-elevation acute coronary syndromes
    Antony George Kaliyadan, Michael P. Savage, Nicholas J. Ruggiero, David Lee Fischman · 2016 · Hospital Practice
  59. Hemostatic Aspects of Cardiovascular Medicine
    Sreekanth Vemulapalli, Richard Clinton Becker · 2013 · Elsevier eBooks
  60. Antiplatelet Therapy for Percutaneous Coronary Intervention: Something Old and Something New
    Michael Angelo Gaglia · 2017 · Current Cardiovascular Risk Reports
  61. Ticagrelor in the Management of Coronary Artery Disease
    Krithika Loganath, Philip D Adamson, Alastair James Moss · 2020 · Future Cardiology
  62. Ticagrelor does not affect left ventricular remodeling following acute myocardial ischemia
    Hyun Kuk Kim, Kyung Seob Lim, Sung Soo Kim, Joo‐Young Na · 2021 · Medical Biological Science and Engineering
  63. Antiplatelet Therapy
    Ryan E. Wilson, Khaled M. Ziada · 2019 · Elsevier eBooks
  64. Le ticagrelor dans les syndromes coronaires aigus : résultats de l’étude PLATO
    Laurent Jacquin, Jean‐Pierre Auffray, J. Bessereau, Anne Champenois, Michel Ostorero, Laurent Bonello · 2011 · Annales françaises de médecine d’urgence
  65. Dual Antiplatelet Therapy After Stent Implantation
    Stephen John Greene, Lora AlKhawam, Muthiah Vaduganathan · 2014 · JAMA
  66. Learning from regional heterogeneity in outcomes of patients with acute myocardial infarction
    Emil Loldrup Fosbøl, Christopher Bull Granger · 2013 · European Heart Journal
  67. Newer antiplatelet agents in acute coronary syndrome
    Albert Ferro · 2016 · BMJ
  68. Response by Park and Park to Letter Regarding Article, “Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial”
    Duk‐Woo Park, Seung‐Jung Park · 2020 · Circulation
  69. Aspirin
    Karsten Schrör, Thomas Hohlfeld · 2014
  70. Platelet Receptors and Drug Targets
    Marco Cattaneo · 2014
  71. Platelet ADP P2Y12Inhibitors: Thienopyridines
    Joseph D. Foley, David J. Moliterno · 2012 · Wiley eBooks
  72. Antiplatelet response to aspirin and clopidogrel in patients with coronary artery disease undergoing percutaneous coronary intervention
    Richard Good · 2014 · Enlighten: Theses (The University of Glasgow)
  73. Ticagrélor versus clopidogrel : étude PLATO Le point de vue du méthodologiste
    Patrick Mismetti, Laurent Bertoletti · 2012 · Archives of Cardiovascular Diseases Supplements
  74. Response to Letter Regarding Article, “Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: A Randomized, Controlled Trial”
    Seung‐Jung Park, Cheol Whan Lee, Jung‐Min Ahn, Duk‐Woo Park, Soo‐Jin Kang, Seung‐Whan Lee, Young‐Hak Kim, Seong‐Wook Park, Seungbong Han, Sang Gon Lee et al. · 2014 · Circulation
  75. High-dose clopidogrel, prasugrel or ticagrelor: trying to unravel a skein into a ball
    Alessandro Aprile, Raffaella Marzullo, Giuseppe Biondi‐Zoccai, Maria Grazia Modena · 2011 · Drugs and Therapy Studies
  76. Ticagrelor
    J. Cada Dennis, Terri L. Levien, E. Baker Danial · 2012 · Hospital Pharmacy
  77. Combination Antithrombotic Management for Non–ST Segment Elevation Acute Coronary Syndromes
    Jayant Bagai, Subhash Banerjee, Emmanouil S. Brilakis · 2013 · Interventional Cardiology Clinics
  78. Balance of Ischemia and Bleeding in Selecting an Antithrombotic Regimen
    Bimmer E.P.M. Claessen, George Dangas, Roxana Mehran · 2013 · Interventional Cardiology Clinics
  79. Invasive management of the acute coronary syndromes
    Tudor Dumitru Vagaonescu, George Dangas · 2012 · Interventional Cardiology
  80. Ticagrelor in the treatment of coronary artery disease patients
    Udaya S. Tantry, Eliano Pio Navarese, Jacek Kubica, Young‐Hoon Jeong, Paul Alfred Gurbel · 2012 · Clinical Practice
  81. Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20–21, 2011, Salvador, Bahia, Brazil
    Renato D. Lópes, Richard Clinton Becker, Laura Kristin Newby, Eric David Peterson, Elaine M. Hylek, Christopher Bull Granger, Mark Andrew Crowther, Tracy S. Wang, Antônio Carlos Carvalho, Otavio B Berwanger et al. · 2012 · Journal of Thrombosis and Thrombolysis
  82. Trans-Atlantic differences in coronary artery bypass grafting: is it the patient, the surgery or the health-care system?
    Miguel Sousa‐Uva, Philippe H. Kolh · 2014 · European Journal of Cardio-Thoracic Surgery
  83. The Prevention of Atherothrombotic Events in Adults with Acute Coronary Syndromes
    Helen Vosper · 2011 · Clinical Medicine Reviews in Vascular Health
  84. The New Dual Antiplatelet Therapy Agents And Their Role in Acute Coronary Syndrome
    Gareth John Williams · 2014 · Res Medica
  85. Advances in Interventional Cardiology New Directions in Antiplatelet Therapy
    Dominick Joseph Angiolillo · 2012
  86. Triple Antiplatelet Therapy in Acute Coronary Syndrome in 2014
    Rajeev Lochan · 2014
  87. PCI Considerations in Women: Gender-Specific Outcomes and Challenges
    Christopher J. Varughese, Rebecca Pinnelas, Jennifer Yu, Roxana Mehran · 2013 · Springer eBooks
  88. Antiplatelet Therapy. New Potent P2Y12 Inhibitors
    Pablo Avanzas y, César Morı́s, Peter Michael Clemmensen · 2013 · Springer eBooks
  89. Schlaganfall aus der Perspektive des Neurologen (Teil 3): Neues in der Sekundärprävention
    Patrick Schur, Andreas Rüdiger Luft · 2016 · Praxis
  90. Anti-Platelet Therapy in Acute Coronary Syndromes: Updates in Therapy After Stent Implantation
    Ryan McKenzie, Andrew Park, Laura V. Tsu · 2012 · Chapman University Digital Commons (Chapman University)
  91. Aggravation of coronary heart disease: the balance of risk and the risk of disease treatment
    V.A. Braznik, Dmitry A. Zateyshchikov · 2015 · Consilium Medicum
  92. Antithrombotic Therapy for Treatment of Acute Ischemic Stroke
    Harold P. Adams, Patricia H. Davis · 2011 · Elsevier eBooks
  93. CLINICAL EVIDENTIAL AND METHODOLOGICAL CHALLENGES OF EARLY ASSESSMENTS OF NEW HEALTH TECHNOLOGIES
    P. Dequen · 2016 · Figshare
  94. Avaliação das variáveis de desempenho no tratamento das síndromes isquêmicas miocárdicas instáveis no Brasil: análise do registro BRACE (Brazilian Registry in Acute Coronary Syndromes)
    Marcelo Franken · 2016
  95. Oral Antiplatelet Agents in PCI
    Jonathan Adam Batty, Joseph Robert Dunford, George Dangas, Vijay Kunadian · 2016 · Interventional Cardiology
  96. PCI Strategies in Acute Coronary Syndromes without ST Segment Elevation ( NSTEACS )
    Georgios E. Christakopoulos, Subhash Banerjee, Emmanouil S. Brilakis · 2016 · Interventional Cardiology
  97. Biometrische Entscheidungs- unterstützung in Zulassung und Nutzenbewertung am
    Armin Koch, Beispiel der Implikationen · 2015
  98. Avaliação das variáveis de desempenho no tratamento das síndromes isquêmicas miocárdicas instáveis no Brasil: análise do registro BRACE (Brazilian Registry in Acute Coronary Syndromes)
    São Paulo · 2016
  99. Caracterização e análise de desfechos clínicos e eventos adversos em pacientes com síndromes coronarianas agudas incluídos em ensaio clínico multicêntrico randomizado de fase III
    Patrícia O. Guimarães · 2017
  100. Balance of Ischemia and Bleeding in Selecting Antithrombotic Regimens
    Bimmer E.P.M. Claessen, Josè P.S. Henriques · 2016 · Interventional Cardiology